MedPath

Citalopram Hydrobromide

Citalopram Oral Solution, USP Rx Only

Approved
Approval ID

e7a2cbdd-1bdb-4e59-a3dd-298a189753ae

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 24, 2023

Manufacturers
FDA

Aurobindo Pharma Limited

DUNS: 650082092

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Citalopram Hydrobromide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65862-074
Application NumberANDA077812
Product Classification
M
Marketing Category
C73584
G
Generic Name
Citalopram Hydrobromide
Product Specifications
Route of AdministrationORAL
Effective DateAugust 24, 2023
FDA Product Classification

INGREDIENTS (6)

CITALOPRAM HYDROBROMIDEActive
Quantity: 10 mg in 5 mL
Code: I1E9D14F36
Classification: ACTIM
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Citalopram Hydrobromide - FDA Drug Approval Details